References

Articles or websites from which pictures were taken are also cited here.



Baize, S. et al. Defective humoral response and extensive intravascular apoptosis are associated with fatal outcome of Ebola virus-infected patients. Nature Med. 5, 423-426 (1999)

Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamadzadeh M, Bavari S, Schmaljohn A. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis. 2003 Dec 1;188(11):1630-8. Epub 2003 Nov 14.

Bruce, J, et al. Ebola Fever: The African Emergency. International Journal of Trauma Nursing 2002. 8 (36): 36-41.

Bray, M. Defense against filoviruses as biological weapons. Antiviral Research 2003, 57: 53-60.

Bray M, Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis. 2003 Dec 1;188(11):1613-7. Epub 2003 Nov 14.

Bray, M. et al Hematological, biochemical and coagulation with a mouse-adapted variant of Ebola Zaire virus. Journal of comparative pathology 125: 243-253 (2001)

Bray M. et al. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. Journal of Infectious Diseases. 178: 651-661 (1998)

Chepurnov AA, et al. Attempt to develop a vaccine against Ebola fever. Vopr Virusol 1995; 40: 257-60

Clegg J.C.S. et al. Vaccines against arenaviruses and filoviruses. New Generation Vaccines. 749-765 (1997)

Connolly B.M. et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. Journal of Infectious Diseases 179: S203-S217

Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.

Enserink M. New Vaccine and Treatment Excite Ebola Researchers. Science, Vol 302, Issue 5648, 1141-1142 , 14 November 2003

Feldmann, Heinz, et al. Ebola virus: from discovery to vaccine. Nature Reviews Immunology 2003. 3: 677-685

Geisbert, T. W. et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 80, 171-186 (2000).

Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis. 2003 Dec 1;188(11):1618-29. Epub 2003 Nov 14.

Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol. 2003 Dec;163(6):2371-82.

Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003 Dec;163(6):2347-70.

Geisbert, T. W, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. The Lancet December 2003. 362:1953-1957

Geisbert T. W, et al. Evaluation in Nonhuman Primates of Vaccines against Ebola Virus.U.S. Army Medical Research Institute of Infectious Diseases against Ebola Virus. http://www.cdc.gov/ncidod/EID/vol8no5/01-0284.htm

Gibb, T. R. et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J. Comp. Pathol. 125, 233-242 (2001).

Gupta M, Mahanty S, Bray M, Ahmed R, Rollin PE. 2001, May. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. Journal of Virology p. 4649-4654

Hart, M. K. Vaccine research efforts for filoviruses. Int. J. Parasitol. 33, 583-595 (2003).

Hevey, M. et al. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251: 28-37 (1998)

Jahrling P.B. et al. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyper immune horses. Arch. Virol. Suppl. 11: 135-140 (1996)

Klenk HD. Will we have and why do we need an Ebola vaccine? doi:10.1038/82126 December 2000 Volume 6 Number 12 pp 1322 - 1323

Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, Froment JM, Bermejo M, Smit S, Karesh W, Swanepoel R, Zaki SR, Rollin PE. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 2004 Jan 16;303(5656):387-90.

Lupton HW, et al. Inactivated vaccine for Ebola virus efficacious in guinea pig model. Lancet 1980; 2: 1294-5

Peters C.J. et al Filoviridae: Marburg and Ebola viruses. Fields Virology 1161-1176 (1996)

Schneider, J., S. C. Gilbert, T. J. Blanchard, T. Hanke, K. J. Robson, C. M. Hannan, M. Becker, R. Sinden, G. L. Smith, and A. V. Hill. 1998. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397-402.

Sullivan, N. J., A. Sanchez, P. E. Rollin, Z.-Y. Yang, and G. J. Nabel. 2000. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408:605-609

Sullivan N, Yang ZY, Nabel GJ. Ebola Virus Pathogenesis: Implications for Vaccines and Therapies. Journal of Virology, September 2003, p. 9733-9737, Vol. 77, No. 18

Sullivan, N. J., T. W. Geisbert, L. Xu, Z.-Y. Yang, M. Roederer, R. A. Koup, P. B. Jahrling, and G. J. Nabel. 2003. Accelerated vaccination for ebola virus hemorrhagic fever in non-human primates. Nature 424:681-684.

Tighe, H., M. Corr, M. Roman, and E. Raz. 1998. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today 19:89-97.

Vanderzanden, L., M. Bray, D. Fuller, T. Roberts, D. Custer, and K. Spik. 1998. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology 246:134-144.

Varkey, Prathibha, et al. Confronting Bioterrorism: Physicians on the front line. Mayo Clinic Proceedings 2002. 77: 661-672.

Vastag B. Ebola Vaccines Tested in Humans, Monkeys. JAMA. 2004;291:549-550.

Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S. Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15889-94.

Wilson, J. A., et al. Ebola virus: the search for vaccines and treatments. Cell. Mol. Life. Sci. 58(2001): 1826-1841

Xiang Z.Q. et al. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219: 220-227 (1996)

Xu, L., A. Sanchez, Z. Yang, S. R. Zaki, E. G. Nabel, S. T. Nichol, and G. J. Nabel. 1998. Immunization for Ebola virus infection. Nat. Med. 4:37-42.

http://www.xenodiaries.org/images/macaque1.jpg (via Google Images: http://images.google.com)

http://www.petwebsite.com/images/guinea_pigs_3.jpg (via Google Images: http://images.google.com)

---

All work remains the property of the respective owners. This website is intended for educational use only and is not intended as a medical resource.
This page last updated: 14 April 2004.